Inventor · disambiguated record
Yue Jiang
Also filed as: JIANG YUE · JIANG YUE-YING
5 granted patents·19 pending applications·3 citations·filing 2002–2025
65Inventor score
Files withJUNO THERAPEUTICS INC9SHAPE THERAPEUTICS INC6CELGENE CORP2ABVITRO LLC1BANJANIN BORA SRECKO1
Top patents by PatentIndex Score
24 records- 0182US11571689B2Synthesis strategy of supported transition metal carbides Fenton-like catalysts and application thereofUNIV TONGJI·Filed 2020·Granted Feb 7, 2023·2 cites·10 claims
- 0276US2025123281A1Uses of anti-bcma chimeric antigen receptorsCELGENE CORP·Filed 2024·Application pending·0 cites
- 0372US11952408B2HPV-specific binding moleculesJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 9, 2024·1 cites·46 claims
- 0470US2025304946A1Immobilized enzyme nanogel and preparation method and application thereofUNIV SHANDONG·Filed 2024·Application pending·0 cites
- 0563US12263190B2Methods and combinations for treatment and T cell modulationJUNO THERAPEUTICS INC·Filed 2019·Granted Apr 1, 2025·0 cites·33 claims
- 0663US2024226298A1Chimeric antigen receptors specific for baff-r and cd19 and methods and uses thereofJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0760US2021128619A1Uses of anti-bcma chimeric antigen receptorsCELGENE CORP·Filed 2020·Application pending·0 cites
- 0860US2025022532A1Regulating enhancer activity using machine-learningSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0958US2025342903A1Methods and systems for transformer-based biological sequence modelsSHAPE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1058US2025026795A1Functional aav capsids for intravitreal administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1157US2025205363A1Functional aav capsids for systemic administrationSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1255US2025356949A1Machine-learning based design of engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1354US2025186503A1Methods and combinations for treatment and t cell modulationJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1454US2025242020A1Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)JUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1553US2025353739A1A piezo photocatalytic process for the production of hydrogen from waterNEWSOUTH INNOVATIONS PTY LTD·Filed 2023·Application pending·0 cites
- 1651US12268741B2Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ROR1)JUNO THERAPEUTICS INC·Filed 2020·Granted Apr 8, 2025·0 cites·49 claims
- 1751US2023178239A1Methods of identifying features associated with clinical response and uses thereofJUNO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1849US2022412954A1Methods of determining attributes of therapeutic t cell compositionsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1946US2025014676A1Generative sequence screening with conditional gans, diffusion models, and denoising diffusion conditional gansSHAPE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2045US2022225597A1Mouse model for assessing toxicities associated with immunotherapiesJUNO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2143US12049667B2High-throughput polynucleotide library sequencing and transcriptome analysisABVITRO LLC·Filed 2018·Granted Jul 30, 2024·0 cites·33 claims
- 2242US2014323348A1EXPRESSION OF G-PROTEIN COUPLED RECEPTORS (GPCRs)UNIV DUKE·Filed 2012·Application pending·0 cites
- 2341US2025364080A1Structural and transformer based machine-learning models for design of engineered guide systems for adenosine deaminase acting on rna editingBANJANIN BORA SRECKO·Filed 2023·Application pending·0 cites
- 2434US2003234079A1Plasma ashing/etching using solid sapphire diskTAIWAN SEMICONDUCTOR MFG·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yue Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →